Advanced Search
Contact | Corporate | Help

Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan

Sponsors:
  • GlaxoSmithKline
Phases:
IndicationsAcronym:
  • Prostatic Hyperplasia
Age Groups:
  • Adult
  • Senior
Gender:
Male
Names:
  • Drug: 5ARI
  • Drug: AB
Enrollment:
35032

Additional information about NCT01323998.


SourceSolution © 2008-2012